The Journal of Infectious Diseases · 1992 · 40 citations · 13 references
Life SciencesImmunologyInfectious DiseasesImmunology Of Infectious DiseasesMolecular VirologyVirologyAntigen RecognitionAntigenic VariationHuman Leukocyte Antigen SystemMajor Histocompatibility ComplexViral EpidemiologyViral InfectionsAntigenic Variation In VirusesImmunodominant AntigensPeptide EpitopesSynthetic Peptide AntigensViral Antigen DetectionViral Antigen Recognition
The heterogeneity of immune responsiveness to the immunodominant epitopes of human T lymphotropic virus (HTLV) types I (MTA-1(162-209)) and II (K-55(162-205)) were determined in natural infections with HTLV-I and -II from diverse geographic areas (n = 285). Of the HTLV-I specimens confirmed by polymerase chain reaction (PCR), all North American (n = 37) and Peruvian (n = 19) specimens reacted with MTA-1. Of HTLV-II specimens confirmed by PCR, 44 (96%) of 46 from North American blood donors, 28 (97%) of 29 from native Americans, and all from intravenous drug users (n = 29) reacted with K-55. Specimens from other geographic areas (Peru, 30; Brazil, 4; Mexico, 10; Italy, 5; Somalia, 13; Ethiopia, 17; Japan, 32; and Jamaica, 15) all reacted either with MTA-1 or K-55. By synthetic peptide-based serologic typing, all of these specimens could be typed as HTLV-I or -II. In addition to the direct implications of these findings for diagnostic purposes, these data provide indirect evidence for the conservation of immunodominant HTLVenv epitopes in diverse geographic populations.
13
Peter L. Nara, Linda Smit, Nancy M. Dunlop et al. · Journal of Virology · 1990 · 226 citations · Full text
Yuetsu Tanaka, Lingjia Zeng, H Shiraki et al. · The Journal of Immunology · 1991 · 136 citations
Peter Horal, William W. Hall, Bo Svennerholm et al. · Proceedings of the National Academy of Sciences · 1991 · 96 citations · Full text